In the meantime have been announcements of delays from vaccine suppliers
European Union leaders gathered Thursday, via videoconference link, to try to inject new energy into the 27-nation bloc’s lagging coronavirus vaccination effort. Accelerate vaccine supplies while maintaining restrictions and no to non-essential travel. This is the line that needs to be followed for EU leaders, according to what emerged on the first day of the European Council meeting. Ample space, in the videoconference comparison, was given to the so-called ‘vaccine passport’, which has long been pushed by southern countries such as Greece and Spain so as not to miss the summer tourism season again. On the vaccination certificate among EU leaders there is “more and more convergence”, assured the president of the European Council, Charles Michel. It will take at least three months to develop the vaccination pass from a technical point of view, explained the president of the EU Commission, Ursula von der Leyen. The idea many are hoping for is summarized by Austrian Chancellor Sebastian Kurz: “We want an EU-wide passport, with which we can travel freely, travel without restrictions for business and go on vacation, as well as finally enjoy gastronomy, culture, events and other things.”
Charles Michel said: ” The next few weeks will remain difficult in terms of vaccination but I give you a message of optimism and hope: we have the means and resources to succeed in the coming months from this crisis in which we have been for more than a year ”. The EU has reached agreements with various companies for over 2 billion doses of vaccines (currently those authorized by the EMA are Pfizer-BioNTech, Moderna and AstraZeneca), but there have been announcements of delays from suppliers. “I can assure you that we are working to increase production,” said AstraZeneca CEO Pascal Soriot, confirming, however, that in the first quarter it will deliver less than half of the vaccines it had committed to supply to the EU. “We are doing our best to supply 40 million doses in the first quarter of 2021,” he said, while 90 million doses were initially scheduled to be delivered in the first quarter.
© Copyright LaPresse